Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
In this study population, giving primary chemotherapy before surgery is an acceptable standard of care for women with advanced ovarian cancer. Funding Cancer Research UK and the Royal College of Obstetricians and Gynaecologists.
Source: The Lancet - Category: Journals (General) Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Funding | General Medicine | Hospitals | OBGYN | Ovarian Cancer | Ovaries | Royal College of Obstetricians and Gynaecologists | Study | Toxicology | Women